Intevac Announces Second Quarter 2018 Financial Results
Mon, July 30 2018
“Our second-quarter results were stronger than forecast, with higher
upgrade revenues in HDD equipment, favorable gross margin performance in
both Thin-film Equipment (“TFE”) and Photonics, and close control of
expenses, leading to a net loss of
“We continued to make progress in our Thin-film Equipment growth
initiatives during the second quarter. A global Top-3 Cellphone maker is
now shipping handsets that incorporate our oDLC® protective coating,
which protects the vibrant decorative color deposited on the back cover
glass of a portion of their flagship models. In Photonics, we have
secured additional government funding for the development of our
next-generation night-vision sensor, which is important validation of
our industry-leading position to provide digital night-vision technology
to the
($ Millions, except per share amounts) | Q2 2018 |
Q2 2017 |
||||||||||||
GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||
Net Revenues | $ | 26.1 | $ | 26.1 |
$ |
31.0 |
$ | 31.0 | ||||||
Operating Income | $ | 0.1 | $ | 0.1 |
$ |
1.3 |
$ | 1.4 | ||||||
Net Income (Loss) | $ | (0.2 | ) | $ | (0.2 | ) |
$ |
1.1 |
$ | 1.1 | ||||
Net Income (Loss) per Share | $ | (0.01 | ) | $ | (0.01 | ) |
$ |
0.05 |
$ | 0.05 | ||||
Six Months Ended |
Six Months Ended |
|||||||||||||
|
|
|||||||||||||
GAAP Results | Non-GAAP Results |
GAAP Results |
Non-GAAP Results |
|||||||||||
Net Revenues | $ | 44.1 | $ | 44.1 | $ | 61.4 |
$ |
61.4 |
||||||
Operating Income (Loss) | $ | (5.1 | ) | $ | (5.0 | ) | $ | 3.4 |
$ |
3.5 |
||||
Net Income (Loss) | $ | (5.3 | ) | $ | (5.2 | ) | $ | 2.9 |
$ |
3.0 |
||||
Net Income (Loss) per Share | $ | (0.24 | ) | $ | (0.23 | ) | $ | 0.13 |
$ |
0.13 |
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section. |
Second Quarter 2018 Summary
The net loss for the quarter was
Revenues were
TFE gross margin was 41.7% compared to 38.4% in the second quarter of 2017 and 35.6% in the first quarter of 2018. The improvement from the second quarter of 2017 was primarily due to product mix, with an increase in HDD upgrades in the second quarter of 2018 compared to the second quarter of 2017, which also had included a lower-margin pilot INTEVAC MATRIX solar ion implant system. The improvement from the first quarter of 2018 was primarily due to a higher mix of higher-margin upgrades, higher revenues and improved factory absorption.
Photonics gross margin was 20.4% compared to 33.4% in the second quarter of 2017 and 6.2% in the first quarter of 2018. The decline from the second quarter of 2017 was primarily due to lower revenue levels, a higher mix of lower-margin research and development contracts and incremental loss provisions recorded on several contracts. The improvement from the first quarter of 2018 was primarily due to improved margins on research and development contracts and smaller loss provisions recorded on contracts. Consolidated gross margin was 37.4%, compared to 37.0% in the second quarter of 2017 and 27.1% in the first quarter of 2018.
R&D and SG&A expenses were
Order backlog totaled
The Company ended the quarter with
First Six Months 2018 Summary
The net loss was
Revenues were
TFE gross margin was 39.4%, compared to 40.7% in the first six months of 2017. We recognized revenue on three 200 Lean HDD systems in the first half of 2018. We recognized revenue on two 200 Lean HDD systems, one pilot INTEVAC MATRIX solar ion implant system, two ENERGi solar ion implant systems and four VERTEX coating systems for display cover panels in the first half of 2017. Photonics gross margin was 13.4% compared to 38.1% in the first six months of 2017. The decline from the first half of 2017 was primarily due lower revenue levels, a higher mix of lower-margin research and development contracts and incremental loss provisions recorded on several contracts. Consolidated gross margin was 33.2%, compared to 40.0% in the first six months of 2017.
R&D and SG&A expenses were
Use of Non-GAAP Financial Measures
Management uses non-GAAP results to evaluate the Company’s operating and
financial performance in light of business objectives and for planning
purposes. These measures are not in accordance with GAAP and may differ
from non-GAAP methods of accounting and reporting used by other
companies.
Conference Call Information
The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 334-0811 prior to the start time. For international callers, the dial-in number is (408) 427-3734. You may also listen live via the Internet at the Company's website, www.intevac.com, under the Investors link, or at www.earnings.com. For those unable to attend, these web sites will host an archive of the call. Additionally, a telephone replay of the call will be available for 48 hours beginning today at 7:30 p.m. EDT. You may access the replay by calling (855) 859-2056 or, for international callers, (404) 537-3406, and providing Replay Passcode 1778375.
About
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of
advanced high-sensitivity digital sensors, cameras and systems that
primarily serve the defense industry. We are the provider of integrated
digital imaging systems for most
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean®, INTEVAC MATRIX®,
INTEVAC VERTEX®, oDLC® and ENERGi® are
registered trademarks of
Safe Harbor Statement
This press release includes statements that constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 (the “Reform Act”).
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share amounts) |
||||||||||||
Three months ended | Six months ended | |||||||||||
|
|
|
|
|||||||||
Net revenues | ||||||||||||
TFE | $ | 20,848 | $ | 22,426 | $ | 33,637 | $ | 43,910 | ||||
Photonics | 5,250 | 8,537 | 10,435 | 17,441 | ||||||||
Total net revenues | 26,098 | 30,963 | 44,072 | 61,351 | ||||||||
Gross profit | 9,761 | 11,470 | 14,636 | 24,517 | ||||||||
Gross margin | ||||||||||||
TFE | 41.7% | 38.4% | 39.4% | 40.7% | ||||||||
Photonics | 20.4% | 33.4% | 13.4% | 38.1% | ||||||||
Consolidated | 37.4% | 37.0% | 33.2% | 40.0% | ||||||||
Operating expenses | ||||||||||||
Research and development | 4,984 | 4,418 | 9,151 | 9,100 | ||||||||
Selling, general and administrative | 4,703 | 5,691 | 10,533 | 11,885 | ||||||||
Acquisition-related1 | 9 | 22 | 8 | 102 | ||||||||
Total operating expenses | 9,696 | 10,131 | 19,692 | 21,087 | ||||||||
Total operating income (loss) | 65 | 1,339 | (5,056) | 3,430 | ||||||||
Income (loss) from operations | ||||||||||||
TFE | 1,220 | 1,749 | (1,289) | 3,608 | ||||||||
Photonics | (444) | 764 | (1,654) | 2,228 | ||||||||
Corporate | (711) | (1,174) | (2,113) | (2,406) | ||||||||
Total operating income (loss) | 65 | 1,339 | (5,056) | 3,430 | ||||||||
Interest and other income (expense) | 133 | 127 | 278 | 237 | ||||||||
Income (loss) before income taxes | 198 | 1,466 | (4,778) | 3,667 | ||||||||
Provision for income taxes | 365 | 366 | 525 | 738 | ||||||||
Net income (loss) | $ | (167) | $ | 1,100 | $ | (5,303) | $ | 2,929 | ||||
Net income (loss) per share | ||||||||||||
Basic | $ | (0.01) | $ | 0.05 | $ | (0.24) | $ | 0.14 | ||||
Diluted | $ | (0.01) | $ | 0.05 | $ | (0.24) | $ | 0.13 | ||||
Weighted average common shares outstanding | ||||||||||||
Basic | 22,461 | 21,495 | 22,284 | 21,356 | ||||||||
Diluted | 22,461 | 23,209 | 22,284 | 22,999 | ||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except par value) |
||||||
|
|
|||||
(Unaudited) | (see Note) | |||||
ASSETS | ||||||
Current assets | ||||||
Cash, cash equivalents and short-term investments | $ | 33,800 | $ | 35,639 | ||
Accounts receivable, net | 24,691 | 20,474 | ||||
Inventories | 33,036 | 33,792 | ||||
Prepaid expenses and other current assets | 2,434 | 2,524 | ||||
Total current assets | 93,961 | 92,429 | ||||
Long-term investments | 4,279 | 6,849 | ||||
Restricted cash | 1,000 | 1,000 | ||||
Property, plant and equipment, net | 11,079 | 12,478 | ||||
Intangible assets, net | 1,196 | 1,503 | ||||
Other long-term assets | 746 | 764 | ||||
Total assets | $ | 112,261 | $ | 115,023 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
Current liabilities | ||||||
Accounts payable | $ | 5,218 | $ | 3,949 | ||
Accrued payroll and related liabilities | 4,825 | 6,818 | ||||
Other accrued liabilities | 10,538 | 7,688 | ||||
Customer advances | 10,552 | 11,026 | ||||
Total current liabilities | 31,133 | 29,481 | ||||
Other long-term liabilities | 2,542 | 2,879 | ||||
Stockholders’ equity | ||||||
Common stock ( |
23 | 22 | ||||
Additional paid in capital | 180,426 | 177,521 | ||||
|
(28,489) | (28,489) | ||||
Accumulated other comprehensive income | 444 | 490 | ||||
Accumulated deficit | (73,818) | (66,881) | ||||
Total stockholders’ equity | 78,586 | 82,663 | ||||
Total liabilities and stockholders’ equity | $ | 112,261 | $ | 115,023 | ||
Note: Amounts as of |
||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (Unaudited, in thousands, except per share amounts) |
||||||||||||
Three months ended |
|
Six months ended |
||||||||||
|
|
|
|
|||||||||
Non-GAAP Income (Loss) from Operations | ||||||||||||
Reported operating income (loss) (GAAP basis) | $ | 65 | $ | 1,339 | $ | (5,056) | $ | 3,430 | ||||
Change in fair value of contingent consideration obligations1 |
9 | 22 | 8 | 102 | ||||||||
Restructuring charges2 |
— | — | 95 | — | ||||||||
Non-GAAP Operating Income (Loss) | $ | 74 | $ | 1,361 | $ | (4,953) | $ | 3,532 | ||||
Non-GAAP Net Income (Loss) | ||||||||||||
Reported net income (loss) (GAAP basis) | $ | (167) | $ | 1,100 | $ | (5,303) | $ | 2,929 | ||||
Change in fair value of contingent consideration obligations1 |
9 | 22 | 8 | 102 | ||||||||
Restructuring charges2 |
— | — | 95 | — | ||||||||
Non-GAAP Net Income (Loss) | $ | (158) | $ | 1,122 | $ | (5,200) | $ | 3,031 | ||||
Non-GAAP Net Income (Loss) Per Diluted Share | ||||||||||||
Reported net income (loss) per diluted share (GAAP basis) | $ | (0.01) | $ | 0.05 | $ | (0.24) | $ | 0.13 | ||||
Change in fair value of contingent consideration obligations1 |
$ | — | $ | — | $ | — | $ | — | ||||
Restructuring charges2 |
$ | — | $ | — | $ | — | $ | — | ||||
Non-GAAP Net Income (Loss) Per Diluted Share | $ | (0.01) | $ | 0.05 | $ | (0.23) | $ | 0.13 | ||||
Weighted average number of diluted shares | 22,461 | 23,209 | 22,284 | 22,999 | ||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010. |
||||||||||||
2Results for the six months ended |
||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20180730005170/en/
Chief Financial Officer
or
Investor Relations
Source: